Skip to content

Clinical trials

Phase 2/3 Dementia trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dementia Phase: Phase 2/3 Country / region: United Kingdom Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20122
20141
20151
20161
20181
20201
20211
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated4
Active, not recruiting2
Completed2
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Washington University School of Medicine6
AstraZeneca1
Axovant Sciences Ltd.1
Janssen Research & Development, LLC1
University College, London1
University of Edinburgh1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dementia11
Alzheimer Disease9
Brain Diseases1
Central Nervous System Diseases1
Cerebral Small Vessel Diseases1
Disease1
Lewy Body Disease1
Mental Disorders1
Nervous System Diseases1
Neurocognitive Disorders1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.